Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones : What should therapists and patients expect
Identifieur interne : 00C187 ( Main/Exploration ); précédent : 00C186; suivant : 00C188Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones : What should therapists and patients expect
Auteurs : J. R. Casley-Smith [Australie] ; Judith R. Casley-Smith [Australie]Source :
- Lymphology [ 0024-7766 ] ; 1996.
Descripteurs français
- KwdFr :
- Administration par voie orale, Administration par voie topique, Anticoagulants (administration et posologie), Anticoagulants (usage thérapeutique), Association thérapeutique, Bras, Coumarines (administration et posologie), Coumarines (usage thérapeutique), Humains, Jambe, Lymphoedème (rééducation et réadaptation), Lymphoedème (traitement médicamenteux), O-(bêta-Hydroxyéthyl)rutosides (administration et posologie), O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique), Résultat thérapeutique, Techniques de physiothérapie.
- MESH :
- administration et posologie : Anticoagulants, Coumarines, O-(bêta-Hydroxyéthyl)rutosides.
- rééducation et réadaptation : Lymphoedème.
- traitement médicamenteux : Lymphoedème.
- usage thérapeutique : Anticoagulants, Coumarines, O-(bêta-Hydroxyéthyl)rutosides.
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Administration, Oral, Administration, Topical, Anticoagulants (administration & dosage), Anticoagulants (therapeutic use), Arm, Chemotherapy, Combined Modality Therapy, Combined treatment, Coumarin, Coumarins (administration & dosage), Coumarins (therapeutic use), Human, Humans, Hydroxyethylrutoside (administration & dosage), Hydroxyethylrutoside (therapeutic use), Leg, Limb, Lymphedema, Lymphedema (drug therapy), Lymphedema (rehabilitation), Oral administration, Physical Therapy Modalities, Physical exercise, Topical administration, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Anticoagulants, Coumarins, Hydroxyethylrutoside.
- chemical , therapeutic use : Anticoagulants, Coumarins, Hydroxyethylrutoside.
- drug therapy : Lymphedema.
- rehabilitation : Lymphedema.
- Administration, Oral, Administration, Topical, Arm, Combined Modality Therapy, Humans, Leg, Physical Therapy Modalities, Treatment Outcome.
Abstract
Using previously presented data, from an open multi-centered trial, the Medians and Third Quartiles were calculated for the overall edema reductions the "average" patient received from an "average" therapist using Complex Physical Therapy (CPT) on 628 lymphedematous limbs. These data provide therapists and patients a general guideline as to the minimal reductions which can be expected in three quarters of patients from average therapists, using CPT with or without the administration of benzo-pyrones. Benzo-pyrones were considered separately: oral (given for three months before and for 11 months after the course of CPT) and topical (during and after CPT). Depending on which measure of edema and its alterations were used, these reductions increased those from CPT alone from 130% to 200% and, after one year, between 150% to 300%. Whereas the effects of oral and topical benzo-pyrones were not statistically different, their combined usage was more effective than use of either alone.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000B86
- to stream PascalFrancis, to step Curation: 000F22
- to stream PascalFrancis, to step Checkpoint: 000B71
- to stream Main, to step Merge: 00CA41
- to stream PubMed, to step Corpus: 005163
- to stream PubMed, to step Curation: 005163
- to stream PubMed, to step Checkpoint: 005163
- to stream Ncbi, to step Merge: 00B821
- to stream Ncbi, to step Curation: 00B821
- to stream Ncbi, to step Checkpoint: 00B821
- to stream Main, to step Merge: 00C458
- to stream Main, to step Curation: 00C187
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones : What should therapists and patients expect</title><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</s1><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, Judith R" sort="Casley Smith, Judith R" uniqKey="Casley Smith J" first="Judith R." last="Casley-Smith">Judith R. Casley-Smith</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</s1><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">96-0336187</idno><date when="1996">1996</date><idno type="stanalyst">PASCAL 96-0336187 INIST</idno><idno type="RBID">Pascal:96-0336187</idno><idno type="wicri:Area/PascalFrancis/Corpus">000B86</idno><idno type="wicri:Area/PascalFrancis/Curation">000F22</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000B71</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000B71</idno><idno type="wicri:doubleKey">0024-7766:1996:Casley Smith J:treatment:of:lymphedema</idno><idno type="wicri:Area/Main/Merge">00CA41</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:8823730</idno><idno type="wicri:Area/PubMed/Corpus">005163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005163</idno><idno type="wicri:Area/PubMed/Curation">005163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005163</idno><idno type="wicri:Area/PubMed/Checkpoint">005163</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005163</idno><idno type="wicri:Area/Ncbi/Merge">00B821</idno><idno type="wicri:Area/Ncbi/Curation">00B821</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B821</idno><idno type="wicri:doubleKey">0024-7766:1996:Casley Smith J:treatment:of:lymphedema</idno><idno type="wicri:Area/Main/Merge">00C458</idno><idno type="wicri:Area/Main/Curation">00C187</idno><idno type="wicri:Area/Main/Exploration">00C187</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones : What should therapists and patients expect</title><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</s1><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, Judith R" sort="Casley Smith, Judith R" uniqKey="Casley Smith J" first="Judith R." last="Casley-Smith">Judith R. Casley-Smith</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</s1><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Lymphology</title><title level="j" type="abbreviated">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="1996">1996</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Lymphology</title><title level="j" type="abbreviated">Lymphology</title><idno type="ISSN">0024-7766</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Administration, Topical</term><term>Anticoagulants (administration & dosage)</term><term>Anticoagulants (therapeutic use)</term><term>Arm</term><term>Chemotherapy</term><term>Combined Modality Therapy</term><term>Combined treatment</term><term>Coumarin</term><term>Coumarins (administration & dosage)</term><term>Coumarins (therapeutic use)</term><term>Human</term><term>Humans</term><term>Hydroxyethylrutoside (administration & dosage)</term><term>Hydroxyethylrutoside (therapeutic use)</term><term>Leg</term><term>Limb</term><term>Lymphedema</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (rehabilitation)</term><term>Oral administration</term><term>Physical Therapy Modalities</term><term>Physical exercise</term><term>Topical administration</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale</term><term>Administration par voie topique</term><term>Anticoagulants (administration et posologie)</term><term>Anticoagulants (usage thérapeutique)</term><term>Association thérapeutique</term><term>Bras</term><term>Coumarines (administration et posologie)</term><term>Coumarines (usage thérapeutique)</term><term>Humains</term><term>Jambe</term><term>Lymphoedème (rééducation et réadaptation)</term><term>Lymphoedème (traitement médicamenteux)</term><term>O-(bêta-Hydroxyéthyl)rutosides (administration et posologie)</term><term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Techniques de physiothérapie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticoagulants</term><term>Coumarins</term><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term><term>Coumarins</term><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticoagulants</term><term>Coumarines</term><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term><term>Coumarines</term><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Administration, Topical</term><term>Arm</term><term>Combined Modality Therapy</term><term>Humans</term><term>Leg</term><term>Physical Therapy Modalities</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Administration par voie orale</term><term>Administration par voie topique</term><term>Association thérapeutique</term><term>Bras</term><term>Humains</term><term>Jambe</term><term>Lymphoedème</term><term>Membre</term><term>Coumarine</term><term>Résultat thérapeutique</term><term>Techniques de physiothérapie</term><term>Voie externe</term><term>Voie orale</term><term>Chimiothérapie</term><term>Exercice physique</term><term>Traitement associé</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Using previously presented data, from an open multi-centered trial, the Medians and Third Quartiles were calculated for the overall edema reductions the "average" patient received from an "average" therapist using Complex Physical Therapy (CPT) on 628 lymphedematous limbs. These data provide therapists and patients a general guideline as to the minimal reductions which can be expected in three quarters of patients from average therapists, using CPT with or without the administration of benzo-pyrones. Benzo-pyrones were considered separately: oral (given for three months before and for 11 months after the course of CPT) and topical (during and after CPT). Depending on which measure of edema and its alterations were used, these reductions increased those from CPT alone from 130% to 200% and, after one year, between 150% to 300%. Whereas the effects of oral and topical benzo-pyrones were not statistically different, their combined usage was more effective than use of either alone.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name></noRegion><name sortKey="Casley Smith, Judith R" sort="Casley Smith, Judith R" uniqKey="Casley Smith J" first="Judith R." last="Casley-Smith">Judith R. Casley-Smith</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00C187 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00C187 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:96-0336187
|texte= Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones : What should therapists and patients expect
}}
| This area was generated with Dilib version V0.6.31. |  |